Project Grant T32AI184340

Award Date 7/5/24
Completion Date 6/30/29
Dollars Obligated $143K
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
San Antonio, TX 78249, USA
Similar Awards
This Project Grant award in the amount of $337,719 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award will fund the "Maryland Infection, Immunization, Intervention, and Impact (M4I) Training Program" at the University of Maryland, Baltimore (UMB), a prominent public research university and academic health center. The M4I program aims to inspire medical students to pursue...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $340,452 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Puerto Rico Comprehensive Cancer Center. The grant, titled "Research Education Program on Microbes, Infections, and Cancer (REPMIC)", will recruit and train 50 post-baccalaureate individuals over 5 years to participate in a 9-month mentored research program focused on understanding the...
This Project Grant award, with a total funding amount of $379,080.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award will support a 2.5-month summer research education program at Western University of Health Sciences to recruit and train 15 qualified, motivated, and research-oriented participants per year from the university's osteopathic medicine, dentistry, optometry,...
This Project Grant award of $402,731 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to increase the number of physician-scientists in pediatrics or obstetrics/gynecology who can apply microbiology, immunology, and research techniques to improve reproductive, maternal, and child health. The grant will support 4 resident physicians to complete one year of laboratory-based training in immunology or...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $185,280 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Texas A&M University System Health Science Center to study how the Mycobacterium tuberculosis (MTB) secreted protein Rv1075c hijacks host histone methyltransferases to promote infection. The key objectives are to define how histone methylation changes at innate immune genes during MTB infection, and investigate how...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $103,952.00 to The Ohio State University to deliver the "STRIVE: Short-Term Research in Immunology and Virology Experience" training program. The program aims to expand, diversify, and strengthen the physician and surgeon scientist pipeline focused on immunology and virology research across various medical...
The National Institute of General Medical Sciences (NIGMS) awarded a $329,646 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of North Texas Health Science Center (UNTHSC) on February 1, 2025. The goal of this project is to support the timely completion of Ph.D. degrees by underrepresented minority groups and their transition into successful biomedical careers. Specifically, the objectives are to: 1) recruit a competitive pool of...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $624,902 to The University of Texas Health Science Center at San Antonio to investigate the role of the HIV accessory protein Vpr in facilitating viral persistence in myeloid cells. The research aims to characterize how Vpr induces epigenetic remodeling at HIV integration sites, which may reveal novel therapeutic...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $352,643 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Maryland, Baltimore (UMB) to establish the Integrated Training Program in Vaccinology (ITP-VAX). The overarching goal of the ITP-VAX program is to encourage more trainees, particularly underrepresented minorities, to join the field of vaccinology and to enable early-career vaccinologists to excel in...
The University of Texas Health Science Center at San Antonio received a $425,647 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 Allergy and Infectious Diseases Research. The grant, awarded on June 20, 2025, supports research to investigate the mechanism of altered immune responses, particularly focused on the role of a specific B cell subset, during obesity. The research aims to provide insight into how obesity-induced expansion of...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $142,599 to the University of Texas at San Antonio (UTSA) to recruit, train, and graduate a diverse group of doctoral students in the multidisciplinary areas of molecular microbiology and immunology. The program aims to provide interdisciplinary training across host-pathogen interactions, immunology, genomics, and disease intervention and vaccines, while cultivating a collaborative training environment focused on professional development, leadership, and scientific communication skills. The project will support 3 Ph.D. students in years 1-2 and 4 students in years 3-5, leveraging additional institutional funding to expand the doctoral program to at least 40 students over the 5-year award period. The grant began on July 5, 2024 and is scheduled for completion on June 30, 2029.

Generated 7/1/25, 3:47 AM